![PAVmed Inc](/common/images/company/N_PAVM.png)
PAVmed Inc is a medical device company engaged in advancing a pipeline of medical technologies from concept to commercialization using a business model focused on capital and time efficiency. Its product includes EsoCheck; CarpX; EsoGuard; PortIO; DisappEAR and others. PAVmed Inc is a medical device company engaged in advancing a pipeline of medical technologies from concept to commercialization using a business model focused on capital and time efficiency. Its product includes EsoCheck; CarpX; EsoGuard; PortIO; DisappEAR and others.
Lucid Diagnostics Launches New Corporate Website PR Newswire NEW YORK, July 11, 2024 NEW YORK, July 11, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a...
Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening...
PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute PR Newswire NEW...
4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer Testing PR Newswire NEW YORK, June 12, 2024 Firefighter #CheckYourFoodTube Precancer Testing Event organized by...
PAVmed Provides Business Update and First Quarter 2024 Financial Results PR Newswire NEW YORK, May 13, 2024 Lucid strengthens balance sheet and secures a July 17, 2024 MolDX pre-submission...
Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results PR Newswire NEW YORK, May 13, 2024 Quarterly EsoGuard® test volume increased 10 percent Strengthened balance...
Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall PR Newswire NEW YORK, May 9, 2024 EsophaCap device recalled due to recent publication of serious device...
Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of Directors PR Newswire NEW YORK, May 7, 2024 Final closing...
PAVmed to Hold a Business Update Conference Call and Webcast on May 14, 2024 PR Newswire NEW YORK, May 3, 2024 Conference Call and Webcast at 8:30 AM Eastern Time NEW YORK, May 3, 2024...
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024 PR Newswire NEW YORK, May 2, 2024 Conference Call and Webcast at 8:30AM Eastern Time NEW YORK, May 2, 2024...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.14 | 16.091954023 | 0.87 | 1.34 | 0.831 | 136211 | 1.03663375 | CS |
4 | 0.139 | 15.9586681975 | 0.871 | 1.34 | 0.5999 | 71854 | 0.90793863 | CS |
12 | -0.73 | -41.9540229885 | 1.74 | 2.4299 | 0.5999 | 66877 | 1.35976037 | CS |
26 | -1.95 | -65.8783783784 | 2.96 | 3.5 | 0.5999 | 63921 | 1.85464572 | CS |
52 | -4.705 | -82.3272090989 | 5.715 | 9 | 0.5999 | 289756 | 4.45323541 | CS |
156 | -73.24 | -98.6397306397 | 74.25 | 145.5 | 0.5999 | 941053 | 42.04751888 | CS |
260 | -14.89 | -93.6477987421 | 15.9 | 145.5 | 0.5999 | 1155595 | 47.0377671 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.